Damien Conover, CFA, is the Editor of Morningstar’s Healthcare Observer as well as an Equities Strategist for Morningstar, Inc. He has been covering the health care industry for nearly a decade with a focus on pharmaceutical and biotechnology companies. Before joining Morningstar in 2007, he held Equity Analyst positions at Raymond James Financial Inc., Bank of Montreal and Tucker Anthony. Mr. Conover is a recognized authority in health care investing, appearing regularly on Bloomberg TV, CNBC and CNN. He holds a bachelor’s and master’s degrees in finance from the University of Wisconsin, where he was a member of the Applied Security Analysis Program.
Big Pharma Moves Toward Orphan Drugs & Emerging Markets - Damien Conover - Morningstar, Inc.
November 14, 2011
Pharmaceutical Companies & Health Care Reform Plans - Damien Conover - Morningstar
November 02, 2009